Our first digital dissolution tester DT 950 Series

The new ERWEKA DT 950 Series is our first digital dissolution tester, equipped with the most advanced embedded PC technology for the requirements of today and the challenges of tomorrow. ERWEKA GmbH is proud to announce the release of its first digital Dissolution Tester - the ERWEKA DT 950 series. Equipped with groundbreaking embedded PC [...]

Yokogawa Adds New Turbidity and Chlorine Analyzers to OpreX Analyzers Lineup

- Bringing high-quality drinking water to the world - Tokyo, Japan -- Yokogawa Electric Corporation (TOKYO: 6841) announces the addition of the TB820D right angle scattered light turbidity detector, FC800D non-reagent type free available chlorine sensor unit, RC800D reagent type residual chlorine sensor unit, FLXA402T liquid analyzer for turbidity and chlorine, and PG400 pulse generator [...]

Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases

Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the new investigator-initiated study, called the Ge-Med [...]

Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.

HighCape Capital Acquisition Corporation The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP. The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, [...]

QIAGEN announces Digital Partner Program with five initial partnerships

Partner program designed to advance Sample to Insight solutions from research to patients leveraging QIAGEN’s unique Knowledge Base Five initial partners sign with QIAGEN Digital Insights (QDI) to grow QIAGENs unique genomic Knowledge Base and accelerate access New partnerships to deliver improved AI services and databases in oncology, secondary analysis and combined NGS panels and [...]

Parse Biosciences Launches Whole Transcriptome Kit to Dramatically Scale Single-Cell Sequencing

Parse Biosciences (https://www.parsebiosciences.com/), a company providing researchers with scalable and flexible single-cell sequencing solutions, announced the launch of its Single Cell Whole Transcriptome Kit. The kit, which was previously available only through Parse’s early-access program, is now generally available to all researchers in North America. The Whole Transcriptome Kit from Parse Biosciences contains everything needed [...]

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio® Sequel® II Systems. The new systems will expand Labcorp’s capacity to [...]

Easy-to-Use Reversed-Phase Capillary Columns and Emitters Improve High-Resolution LC-MS Analysis

The Thermo Scientific MAbPac Reversed-Phase Capillary HPLC Columns and Emitters achieve sensitive, reproducible and robust high throughput analysis with minimal sample volume VILNIUS, Lithuania – Proteomics, clinical peptides and biopharmaceutical research laboratories performing high throughput, high-performance liquid chromatography (HPLC), or liquid chromatography-mass spectrometry (LC-MS) analysis can now benefit from novel capillary chromatography columns and nano- [...]

Leading Drug Discovery and Development Company Harmonizes Data Analysis Workflows Across All R&D Sites Worldwide Using Genedata Screener

Leading drug discovery and development partnership company Evotec deploys market-leading software platform for support of its broad and innovative assay and screening portfolio, gaining speed and efficiency Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Evotec, the global drug discovery alliance and development partnership company, has [...]

Twist Bioscience and Victorian Clinical Genetic Services Collaborate on Development of Novel Whole Exome Capture Diagnostic Assay

- Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services - SOUTH SAN FRANCISCO, Calif. --  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based specialist provider of prenatal, childhood and adult genetics [...]

Access IBO on Knowledge Center